Canadian health authorities have suspended the use of AstraZeneca Covid-19 vaccine for those under the age of 55 due to growing concerns over side effects of formation of fatal blood clots. In a statement, Health Canada said the action came in the light of information being reported from Europe about additional cases of the ‘very rare adverse events’ of 'thrombosis (blood clots) with thrombocytopenia (low blood platelets) occurring after immunization with the AstraZeneca vaccine.’ Health Canada issued ‘additional terms and conditions’ to the manufacturers of the vaccine, Astra Zeneca as well the Serum Institute of India and its Canadian partner Verity Pharmaceuticals. Watch the full video for more.
